Roughly one-third of adults in the United States are obese. 1 Adult obesity is an independent risk factor for a wide range of noncommunicable diseases, including cardiovascular disease, 2 type 2 diabetes, metabolic syndrome, 3 sleep apnea, 4 and arthritis. [5] [6] [7] [8] [9] It is a significant cause of disability, [10] [11] [12] excess mortality, [13] [14] [15] [16] lower productivity, 17 and higher medical costs. [18] [19] [20] Moreover, without significant intervention, it is estimated that half or more of the American adult population will be obese by 2030, 21, 22 further eroding the health of the population and straining the health care system. Thus, a reduction in adult obesity prevalence has the potential to realize substantial health and economic benefits.
One of the primary strategies to address adult obesity is prevention efforts targeting youth. Although recently released data reveal slight decreases in childhood obesity prevalence in some states, 23 nearly a fifth of children aged between 6 and 19 years remain obese, more than twice the prevalence just 2 decades ago. 24, 25 Moreover, the prevalence of extreme childhood obesity (BMI for age $99th percentile based on the 2000 Centers for Disease Control and Prevention growth charts) continues to increase, 26 and longitudinal studies show that 77% to 92% of obese teenagers remain obese in adulthood. [27] [28] [29] Thus, addressing adult obesity necessitates tackling childhood obesity. Not surprisingly, the US Task Force on Childhood Obesity has set the goal of reducing obesity prevalence among youth to 5% by 2030. 30 Efforts to address childhood obesity come at a significant cost. The recent improvements cited earlier may be a result of the resources that have already been channeled toward childhood obesity prevention and treatment efforts. For example, in 2007 the Robert Wood Johnson Foundation pledged $500 million to fund such initiatives over the next 5 years. 31 In 2010, the California Endowment announced a 10-year, $1-billion program to build healthpromoting communities across the state, partly in efforts to address childhood obesity. 32 The federal government and many state and local governments have also allocated resources directly for childhood obesity prevention efforts.
Policymakers are routinely asked to justify the value of childhood obesity prevention efforts, in both health and economic terms. One strategy for quantifying the economic value is to document the incremental lifetime costs of an obese child relative to a normal weight child. This estimate, which can also be used in cost-effectiveness analyses, provides a benchmark of the potential per capita savings that could accrue from successful obesity prevention and treatment efforts. Thus, the goal of this article is to review and update the literature to identify the best current estimate of the incremental lifetime per capita medical cost of an obese child in the United States today relative to a normal weight child. We also report the total excess costs of childhood obesity for 1 age cohort, 10-yearold children with obesity, in efforts to provide an estimate of the magnitude of these costs in aggregate.
Our determination of the most appropriate estimate is based on the quality and generalizability of the included studies. An appropriate estimate incorporates the following core components: differential costs by age and BMI from childhood until death, differential life expectancy for those at higher BMI values, and discounting to take into account the time value of money. Additionally, whereas most obese children will remain obese in adulthood, 33, 34 roughly two-thirds of normal weight children will eventually become overweight or obese 28, 29, 35 and incur the resulting increase in health care costs and reduced life expectancy. If one believes that a particular childhood obesity intervention will only delay eventual increases in weight, as opposed to keeping a child at a normal weight throughout life, then an appropriate estimate of the incremental lifetime medical costs of an obese child relative to a normal weight child should take this eventual weight gain into consideration. Otherwise, the results would be biased in favor of higher estimates of potential savings. We present results under both scenarios because the appropriate estimate to report and use will depend on the context of the question at hand.
LITERATURE SEARCH
To identify candidate estimates, we conducted a systematic literature search in May 2013 using PubMed and Web of Science. Figure 1 depicts the literature search and article selection process. The search terms "obesity", "child", "adolescent", "cost of illness", and "lifetime cost" were used for PubMed. These terms were entered as free text and as Medical Subject Headings terms where applicable. The search results of like terms, such as "cost of illness" and "lifetime cost", were combined using the OR function. The AND function was then used to retrieve studies that matched all 3 search themes: obesity, age group, and cost. When the search terms were applied to the Web of Science database, only 58 articles were retrieved. Therefore, the search terms "obesity" and "cost" were used to generate additional articles. A total of 2779 articles were identified by using both databases. Duplicates of 11 studies that appeared on both databases were removed. Of the remaining 2768 studies, 2675 were excluded because they did not report direct medical costs of obesity. The full-text articles of 93 remaining studies were assessed for eligibility. Of these, 42 studies were excluded because they were not based on US data. Another 45 studies were excluded because they were published .15 years ago and thus are unlikely to reflect today' s medical cost profile, the per-person lifetime cost of obesity was not reported or could not be determined from the reported data, or they were reviews or commentaries. The reference lists of these reviews and the 6 shortlisted articles [36] [37] [38] [39] [40] [41] were manually reviewed but did not yield additional articles for inclusion in the review. Column 1 of Table 1 provides the lead author and year of the 6 included studies.
Evaluation of Existing Unadjusted Estimates
The identified studies were evaluated in context of the core components listed earlier. Table 2 provides a summary of the key features of the selected studies.
Differential Costs by Age and BMI From Childhood Until Death
All studies recognized that direct lifetime medical costs are higher for obese people than for those of normal weight.
However, not all studies accounted for the differential costs starting from childhood. Thompson Although all studies incorporated higher annual medical cost estimates for obese people, the approach differed across studies. Thompson et al 36 accounted for higher costs by estimating the excess risk borne by obese people of 5 obesity-related medical conditions: hypertension, hypercholesterolemia, type 2 diabetes, coronary heart disease, and stroke, and multiplying the population attributable fraction for obese people by the estimated direct medical costs of each condition. They estimated different risk profiles for 3 distinct decades of life from 35 to 64 years. Tucker et al 37 assumed that direct medical costs increased by 2.3% for each BMI unit above 25 and by 1.3% for each additional year in age based on published estimates. 42 Four studies used multivariate regression analyses to predict annual direct medical costs of individuals as a function of BMI while controlling for other characteristics such as gender, age, race or ethnicity, insurance, income, and education. [38] [39] [40] [41] In 2 studies, 38, 39 interaction terms of BMI or BMI category with age were used to generate agespecific estimates of the incremental costs for those in selected BMI categories. Trasande 40 and Ma and Frick, 41 on the other hand, assumed a single incremental cost of adult obesity that did not vary by age. This increases the likelihood of overstating lifetime costs, because annual obesity-related costs have been shown to start small and increase with age. 38, 43, 44 Trasande 40 accounted for this overstatement by reducing his final estimate by 38%.
All the studies stratified the age-and BMI-specific medical costs by gender. Three studies 37, 38, 41 also stratified the costs by race or ethnicity, and 1 study 41 further stratified results by smoking status.
Differential Life Expectancy by BMI
It is well documented that obesity decreases life expectancy. 15, 16, [45] [46] [47] [48] [49] [50] Therefore, it is imperative for studies of lifetime costs to account for differential life expectancy between normal weight and heavier adults.
Five out of 6 studies considered the elevated mortality risk of heavier people in their estimates of lifetime costs. [36] [37] [38] [39] 41 Thompson et al 36 calculated the life expectancy of people with different BMI and comorbidity profiles from published and unpublished sources. Tucker et al 37 
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Discounting to Account for the Time Value of Money
All studies applied a 3% discount rate for calculating lifetime cost estimates.
BMI Transitions Over the Lifetime
Only 2 studies incorporated weight transitions over time. The second set of calculations related to obtaining the present value of the estimates provided in the various studies. For each exposition, we chose to present costs from the perspective of a 10-year-old obese child. As noted earlier, starting ages for the accrual of lifetime obesity-related medical costs differed across the selected studies. For each study, we used the youngest age or age range (and used the midpoint) as the starting age and the corresponding cost estimates. For comparability, once the starting age and the associated lifetime cost estimates were elicited, all estimates were inflated to 2012 dollars using the medical care portion of the Consumer Price Index for all urban consumers 54 and discounted to reflect costs from the perspective of a 10-year-old child today (note that the estimates of 1 study 41 were inflated for 4 years because their estimates began at age 6). Next, we filled in gaps for studies that did not account for increased costs in certain age ranges. The annual obesity-attributable medical cost per overweight child has been estimated at $240 (2012 dollars) for children aged 8 to 13 years and $320 (2012 dollars) for children aged 14 to 19 years old. 43 To account for costs between ages 20 and 39, we imputed estimates based on figures reported in Finkelstein et al. 38 We added the present value discounted costs for missing age ranges to the adjusted lifetime cost estimates for the 4 studies that needed this adjustment. [36] [37] [38] [39] Three studies reported separate estimates only by gender and age. 36, 39, 40 The remaining 3 studies reported separate estimates by race in addition to gender and age. 37, 41, 43 Ma and Frick 41 went a step further to report estimates by smoking status. To generate a single cost estimate, we calculated a weighted average of the estimates for given subpopulations included in each study, with weights based on the proportion of the 2011 US population ages 0 to 17 years who are non-Hispanic white, African American, and Hispanic males and females. 55 Similarly, the proportions of current smokers ages 14 to 17 years by gender and race estimated from the 2009 National Youth Tobacco Survey 56 were used to collapse the subcategories reported by Ma and Frick. Research shows that the majority of adult smokers begin smoking by age 18. 57 Thus, the estimates of smoking prevalence among high school students are reasonable approximations for the calculation of this weighted average.
RESULTS
After the adjustments discussed in the previous section are incorporated, the incremental lifetime direct medical cost from the perspective of a 10-yearold obese child relative to a 10-year-old normal weight child ranges from $12 660 to $19 630 when weight gain through adulthood among normal weight children is accounted for (based on 2 studies: Tucker et al 37 and Trasande 40 ), and from $16 310 to $39 080 when such weight is not accounted for (based on 4 studies: Thompson et al, 36 Wang et al, 39 Finkelstein et al, 38 and Ma and Frick 41 ). 59 On a per capita basis, the cost of 1 year of college (including tuition, fees, books, room and board, and other expenses) at a public 4-year institution is roughly $16 930. 60 Thus, each case of childhood obesity that could be prevented and maintained (at no cost) would allow for funding $1 year of a child' s college education. When the most conservative estimate of $12 660 is applied, the total direct medical cost for the same cohort of 10-year-olds falls to $9.4 billion. Even so, this amount is 62 times the 2012 to 2013 funding for the nationwide Fresh Fruit and Vegetable Program, which has been shown to increase the consumption of fruits and vegetables among students in participating schools. 61, 62 It is worth reiterating that because the adverse health effects of obesity do not occur until well into adulthood and future costs are discounted, the lifetime cost of obesity is highly influenced by whether one focuses on children or adults. Ironically, the lifetime costs of obesity are actually greater for adults than for children. This is not to say that obesity prevention and treatment efforts should not target youth but only that the economic case for doing so is limited if one focuses solely on the incremental costs. This narrow view does not consider the reality that prevention efforts typically do not just target overweight youth. There is the potential to improve weight management among all youth that could last well into adulthood. The medical cost estimates also do not consider other benefits that could be achieved through successful obesity prevention efforts. They do not account for obesity' s effect on health-related quality of life or on nonmedical costs. Research has shown that among full-time workers, the indirect costs of obesity, including increased absenteeism and presenteeism (reduced on-the-job productivity) account for 59% of the total. 63 Considering these or other nonmedical costs would further improve the business case for childhood (and adult) obesity prevention efforts. This should be an area of future research.
